Increased ΤGF-β3 in primary biliary cirrhosis: An abnormality related to pathogenesis?

Figure 1 Transforming growth factor-β1 (A), transforming growth factor-β2 (B) and transforming growth factor-β3 (C). A: Box plots showing the interquartile range (box), median (horizontal line) and range (vertical lines) of the serum levels of transforming growth factor-β1 (TGF-β1) in normal controls, patients with hepatocellular carcinoma (HCC), viral cirrhosis, chronic active hepatitis C (CAH), primary biliary cirrhosis (PBC) stages I-II, PBC stages III-IV, in hepatic vein blood from PBC and viral cirrhosis patients (central). B, C: Box plots showing the interquartile range (box), median (horizontal line) and range (vertical lines) in the peripheral and hepatic vein serum levels of TGF-β2 and TGF-β3 of the same group of patients. ^aP < 0.05, ^bP < 0.01, ^dP < 0.001.